[Federal Register Volume 70, Number 235 (Thursday, December 8, 2005)]
[Notices]
[Pages 73006-73007]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-7038]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-06-0009]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-4766 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    National Disease Surveillance Program--I. Case Reports--Revision--
(NCID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Formal surveillance of 18 separate reportable diseases has been 
ongoing to meet the public demand and scientific interest in accurate, 
consistent, epidemiologic data. These ongoing disease reports include: 
Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob Disease 
(CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-
lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease, 
Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial 
Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis. 
Tularemia is a new addition to this submission. Case report forms from 
state and territorial health departments enable CDC to collect 
demographic, clinical, and laboratory characteristics of cases of these 
diseases. This information is used to direct epidemiologic 
investigations, identify and monitor trends in reemerging infectious 
diseases or emerging modes of transmission, to search for possible 
causes or sources of the diseases, and develop guidelines for 
prevention and treatment. The data collected will also be used to 
recommend target areas most in need of vaccinations for selected 
diseases and to determine development of drug resistance.
    Because of the distinct nature of each of the diseases, the number 
of cases reported annually is different for each. There is no cost to 
respondents other than their time.

[[Page 73007]]



                                       Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
                                                     Number of
              Form                   Number of     responses per       Total       Hrs/response    Total burden
                                    respondents     respondent       responses
----------------------------------------------------------------------------------------------------------------
ABCs............................             329              21            6909           10/60            1152
CJD.............................              20               2              40           20/60              13
Cyclospora......................              55              10             550           15/60             138
Dengue Case Investigation.......              55             182          10,010           15/60           2,503
Hantavirus Pulmonary Syndrome...              40               3             120           20/60              40
Idiopathic CD4+T-lymphocytopenia              10               2              20           10/60               3
Kawasaki Syndrome...............              55               8             440           15/60             110
Legionellosis Case Report.......              23            11.7             269           20/60              90
Lyme Disease Report.............              52             261          20,020            5/60           1,668
Malaria Case Surveillance Report              55              20           1,100           15/60             275
Plague Case Investigation Report              55            0.20              11           20/60               4
Q Fever.........................              55               1              55           10/60               9
Reye's Syndrome Case                          50               1              50           20/60              17
 Surveillance Report............
Tick-borne Rickettsial Disease                55              18             990           10/60             165
 Case Report....................
Trichinosis Surveillance Case                 55            0.70              39           20/60              13
 Report.........................
Tularemia.......................              55             2.2             121           20/60              40
Typhoid Fever Surveillance                    55               7             385           20/60             128
 Report.........................
Viral Hepatitis Case Record.....              55             200          11,000           25/60           4,583
                                 -----------------
    Total.......................  ..............  ..............  ..............  ..............          10,950
----------------------------------------------------------------------------------------------------------------


    Dated: December 2, 2005.
Joan Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E5-7038 Filed 12-7-05; 8:45 am]
BILLING CODE 4163-18-P